The CCL5/CCR5 axis has been demonstrated to promote cancer cell migration through the recruitment and modulation of inflammatory cell activities, followed by the generation of an immunosuppressive environment including TAMs and MDSCs in BC [79,80,161]. Here, CCL5 is linked to breast cancer.